# Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dapagliflozin-versus-glipizide-as-add-on-therapy-in-patients-with-type-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael A. Nauck,Stefano Del Prato,Juris J. Meier,S. Durán‐García,Katja Rohwedder,M. Elze,Shamik Parikh |
| Citations | 534 |
| DOI | 10.2337/dc11-0606 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://care.diabetesjournals.org/content/diacare/34/9/2015.full.pdf |
| OpenAlex ID | https://openalex.org/W2008443217 |
| PMID | 21816980 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Katja Rohwedder](https://scholariq.org/researchers/katja-rohwedder/)

## Paper journal

- [Diabetes Care](https://scholariq.org/journals/diabetes-care/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.